Bacta

AI-powered bioproduction for industrial ingredients

Founded 2024 · $3.6M raised

Founded
2024
Business Model
B2B
Website
bacta.bio
Total Funding
$3.6M
Last Round
$3.6M Pre-SeedOct 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

baCta builds an AI-powered bioproduction platform that uses engineered microorganisms as programmable molecular factories for industrial ingredients. Astaxanthin is its first commercial molecule, with ingredients offered in multiple forms and transparent traceability for cosmetics, human nutrition, and animal nutrition markets. The platform combines a genome-to-factory AI model for predictive throughput, a precision biofoundry that pairs wet-lab automation with AI, and full-stack bioproduction spanning fermentation and downstream processing to industrial scale. The company’s mission is to produce the vast majority of industrial ingredients with microorganisms and enable sustainable abundance of valuable molecules.

Summary

Bacta is an Artificial Intelligence company, founded in 2024. It has raised $3.6M in total across 2 rounds, most recently a $3.6M Pre-Seed round in Oct 2024. Investors include LocalGlobe, Kima Ventures and another.vc.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-SeedOct 2024
$3.6M

Sign up to see all 2 events

Funding: Pre-Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Crusoe

AI infrastructure company building renewable-powered data centers and cloud compute optimized for...

Denver, United States201–500Artificial Intelligence, Clean Energy
Series FTotal funding$9.4BSep 2026
CruiseClosed

Self-driving cars.

San Francisco, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Growth EquityTotal funding$6.9BJan 2021
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bacta on Indexed.vc
<a href="https://indexed.vc/companies/bacta"><img src="https://indexed.vc/api/badge/company/bacta" alt="Bacta on Indexed.vc" width="260" height="76" /></a>